Welcome to our dedicated page for Talphera news (Ticker: TLPH), a resource for investors and traders seeking the latest updates and insights on Talphera stock.
Talphera, Inc. reports news centered on its specialty pharmaceutical development business, with recurring updates on Niyad, nafamostat research, continuous renal replacement therapy and medically supervised care settings. Company announcements commonly cover financial results, corporate updates, clinical-study developments, research presentations and regulatory designations tied to the Niyad program.
Other recurring Talphera news includes financings involving common stock and pre-funded warrants, board and governance changes, investor events and business updates related to its development-stage pharmaceutical portfolio.
Summary not available.
Summary not available.
Summary not available.
Summary not available.